MedPath

Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients

Not Applicable
Completed
Conditions
Adverse Effect of Radiation Therapy
Breast Neoplasms
Radiodermatitis
Registration Number
NCT02922244
Lead Sponsor
Chulabhorn Cancer Center
Brief Summary

The herbal products on reduction of radiation-induced dermatitis in patients with breast cancer

Detailed Description

To compare the effect of each herb extracts to protect the skin from the adverse effects of radiation therapy in patients with breast cancer with herbal extract products.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Aged 20 years old or older,
  • Diagnosed with Breast cancer
  • On course of external Radiation therapy
Exclusion Criteria
  • Pregnant
  • Previously underwent external Radiation therapy
  • Illiterate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change of dermatitis gradingChange from baseline dermatitis grading at 1, 2, 3, 4, 5 weeks and at 9 week.

RTOG (Radiation Therapy Oncology Group) Cooperative Group Common Toxicity Criteria Skin Grade 0:None or no change Grade 1:Scattered macular or papular eruption or erythema that is asymptomatic Grade 2:Scattered macular or papular eruption or erythema with pruritis or other associated symptoms Grade 3:Generalized symptomatic macular, papular, or vesicular eruption Grade 4:Exfoliative dermatitis or ulcerating dermatitis Grade 5:If that toxicity caused the death of the patient.

Secondary Outcome Measures
NameTimeMethod
Patient satisfaction with the creamAt 9 week from date of randomization

Scoring 1-4

1. not satisfied

2. slightly satisfied

3. moderately satisfied

4. very satisfied

Trial Locations

Locations (1)

ChulaBhorn Hospital

🇹🇭

Bangkok, Thailand

ChulaBhorn Hospital
🇹🇭Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.